Indaptus Therapeutics, Inc. (INDP)
Develops immunotherapy drugs to treat cancer and viral infections like HIV.
$1.75-0.14%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-76.1%
The outlook
INDP is trading near its 52-week low, well below both its 50- and 200-day moving averages, signaling a weak near-term trend. Analyst coverage appears limited, and the overall sentiment leans bearish based on current market positioning.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range9% of the way from its 52-week low to high
Market cap
$232.5M
52-wk high
$10.40
52-wk low
$0.92
50-day avg
$2.61
200-day avg
$2.49
Trailing P/E
—